HLA-B27: Portraying immunodominant viral epitopes

European Journal of Immunology

Volumn 35, Issue 2, 2005, Pages 336-340

  López de Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Epstein Barr; HIV; HLA B27; Influenza; MHC

Indexed keywords

CELL RECEPTOR; EPITOPE; HLA B27 ANTIGEN; MICROORGANISM PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; EPSTEIN BARR VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INDIVIDUALITY; INFLUENZA VIRUS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; SPONDYLOSIS; T LYMPHOCYTE; X RAY DIFFRACTION;

ANTIGENS, VIRAL; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; KILLER CELLS, NATURAL; LIGANDS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SPONDYLARTHROPATHIES;

EID: 14744286856     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425875     Document Type: Article

References (30)

1. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C., Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987. 329: 506-512.
2. Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. and Sturrock, R. D., Ankylosing spondylitis and HL-A 27. Lancet 1973. 1: 904-907.
3. Brewerton, D. A., Caffrey, M., Nicholls, A., Walters, D., Oates, J. K. and James, D. C., Reiter's disease and HL-A 27. Lancet 1973. 2: 996-998.
4. Benjamin, R. and Parham, P., Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 1990. 11: 137-142.
5. Mear, J. P., Schreiber, K. L., Münz, C., Zhu, X., Stevanovic, S., Rammensee, H. G., Rowland-Jones, S. L. and Colbert, R. A., Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 1999. 163: 6665-6670.
6. Allen, R. L., Raine, T., Haude, A., Trowsdale, J. and Wilson, M. J., Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 2001. 167: 5543-5547.
7. Kollnberger, S., Bird, L., Sun, M. Y., Retiere, C., Braud, V. M., McMichael, A. and Bowness, P., Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum. 2002. 46: 2972-2982.
8. Madden, D. R., Gorga, J. C., Strominger, J. L. and Wiley, D. C., The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991. 353: 321-325.
9. Stewart-Jones, G. B. E., di Gleria, K., Kollnberger, S., McMichael, A. J., Jones, E. Y., and Bowness, P., Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 2005. 35: this issue.
10. Madden, D. R., Garboczi, D. N. and Wiley, D. C., The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2 [published erratum appears in Cell 1994 Jan 28. 76(2): following 410]. Cell 1993. 75: 693-708.
11. Gomard, E., Sitbon, M., Toubert, A., Begue, B. and Levy, J. P., HLA-B27, a dominant restricting element in antiviral responses? Immunogenetics 1984. 20: 197-204.
12. Goulder, P. J., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A. et al., Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 1997. 3: 212-217.
13. Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P. et al., Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 2001. 193: 375-386.
14. Lopez de Castro, J. A., Alvarez, I., Marcilla, M., Paradela, A., Ramos, M., Sesma, L., and Vazquez, M., HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004. 63: 424-445.
15. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R. and Wiley, D. C., Identification of self peptides bound to purified HLA-B27. Nature 1991. 353: 326-329.
16. Hillig, R. C., Huelsmeyer, M., Saenger, W., Welfle, K., Misselwitz, R., Welfle, H., Kozerski, C., Volz, A., Uchanska-Ziegler, B. and Ziegler, A., Thermodynamic and structural analysis of peptide-and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 2004. 279: 652-663.
17. Ramos, M. and Lopez de Castro, J. A., HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 2002. 60: 191-205.
18. Hülsmeyer, M., Fiorillo, M. T., Bettosini, F., Sorrentino, R., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 2004. 199: 271-281.
19. Ramos, M., Paradela, A., Vazquez, M., Marina, A., Vazquez, J. and Lopez de Castro, J. A., Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J. Biol. Chem. 2002. 277: 28749-28756.
20. Sesma, L., Montserrat, V., Lamas, J. R., Marina, A., Vazquez, J. and Lopez de Castro, J. A., The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. J. Biol. Chem. 2002. 277: 16744-16749.
21. Bowness, P., Allen, R. L., Barclay, D. N., Jones, E. Y. and McMichael, A. J., Importance of a conserved TCR Jα-encoded tyrosine for T cell recognition of an HLA B27/peptide complex. Eur. J. Immunol. 1998. 28: 2704-2713.
22. Bowness, P., Moss, P. A., Rowland-Jones, S., Bell, J. I. and McMichael, A. J., Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Eur. J. Immunol. 1993. 23: 1417-1421.
23. Fiorillo, M. T., Ruckert, C., Hulsmeyer, M., Sorrentino, R., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 2004. In press: published online as Manuscript M410807200.
24. Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A. and Long, E. O., Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995. 267: 1016-1018.
25. Peruzzi, M., Wagtmann, N. and Long, E. O., A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 1996. 184: 1585-1590.
26. Peruzzi, M., Parker, K. C., Long, E. O. and Malnati, M. S., Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 1996. 157: 3350-3356.
27. Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G. and Sun, P. D., Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000. 405: 537-543.
28. Fan, Q. R., Long, E. O. and Wiley, D. C., Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2001. 2: 452-460.
29. Hülsmeyer, M., Hilling, R. C., Volz, A., Rühl, M., Schröder, W., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 2002. 277: 47844-47853.
30. Khan, M. A., Update on spondyloarthropathies. Ann. Intern. Med. 2002. 136: 896-907.